SEC Form 4 · accession 0001645627-18-000062
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Sep 28, 2018
Accepted (ET)
Oct 2, 2018 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 28, 2018 | P | 1,000 | $0.0496 | A | 25,971,898 | D | |
| Common Stock | Sep 28, 2018 | P | 1,000 | $0.05 | A | 25,972,898 | D | |
| Common Stock | Sep 28, 2018 | P | 1,000 | $0.0496 | A | 25,973,898 | D | |
| Common Stock | Sep 28, 2018 | P | 1,000 | $0.0496 | A | 25,974,898 | D | |
| Common Stock | Sep 28, 2018 | P | 2,000 | $0.05 | A | 25,976,898 | D | |
| Common Stock | Sep 28, 2018 | P | 2,000 | $0.052 | A | 25,978,898 | D |
Table II — derivative securities
No Table II lines on this filing.